A consortium of seven pharma companies has been formed with the aim of sharing knowledge on and harmonizing approaches to oligonucleotide development. This letter aims to raise awareness of this new group and to set expectations for future publications.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/2168479018793626 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!